Novartis AG (NVS)
NYSE: NVS · Real-Time Price · USD
151.26
-2.11 (-1.38%)
Jul 14, 2026, 12:08 PM EDT - Market open

Novartis AG Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
CurrentQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jul '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
280,725291,461263,077246,066234,258218,418192,196229,959215,537197,369206,386198,126197,498182,599181,968154,720174,601183,733184,986173,129
Market Cap Growth
19.84%33.44%36.88%7.00%8.69%10.66%-6.88%16.07%9.13%8.09%13.42%28.06%13.11%-0.62%-1.63%-10.63%-9.59%1.17%-8.27%-7.50%
Enterprise Value
320,735331,897287,363268,757259,964242,575210,220248,222236,258215,040218,480210,701214,748199,626191,083164,233186,011196,424187,917199,462
Last Close Price
151.26152.75137.87128.24121.01111.4897.31115.02106.4696.73100.9796.3995.4987.0685.8571.9379.9983.0482.7777.39
PE Ratio
20.7421.8819.2817.5417.6417.4516.5813.4113.5413.1114.2225.9126.6026.7927.087.407.837.747.7917.87
PS Ratio
4.965.154.644.374.244.103.724.604.414.134.424.324.433.984.193.083.313.474.2112.38
PB Ratio
7.217.575.705.555.585.694.365.315.164.974.425.193.813.513.072.542.772.992.733.05
P/TBV Ratio
---------------593.97397.43-48.09-
P/FCF Ratio
16.0116.6214.9512.5712.1212.4111.8315.5815.4915.6115.4013.2113.7412.5713.6612.0713.5513.9213.2112.59
P/OCF Ratio
14.6415.2013.7411.6811.2711.5010.9114.4014.3114.3414.2712.3712.8511.7512.7811.0412.2812.5912.2711.40
EV/Sales Ratio
5.675.875.074.774.714.564.064.974.844.514.684.604.824.354.403.273.523.714.2714.26
EV/EBITDA Ratio
13.9914.7512.5011.7111.4511.1610.1812.6220.1420.4312.0423.5623.8523.6912.8110.1617.1016.2012.0311.17
EV/EBIT Ratio
17.4119.2816.2915.3115.5815.3214.4518.2620.1420.4322.3623.5623.8523.6924.0517.3517.1016.2018.6916.95
EV/FCF Ratio
18.2918.9316.3313.7313.4513.7812.9316.8216.9817.0016.3114.0514.9413.7514.3512.8214.4314.8813.4214.50
Debt / Equity Ratio
1.001.000.640.540.570.600.520.580.510.470.430.510.380.420.370.350.380.390.360.43
Debt / EBITDA Ratio
2.098.646.885.535.345.346.055.745.628.096.2914.306.246.2715.937.4513.957.197.607.34
Debt / FCF Ratio
2.6814.1121.425.155.159.228.645.396.2813.3912.354.928.4610.747.356.348.8922.529.087.51
Net Debt / Equity Ratio
1.041.040.520.500.610.630.410.420.490.440.260.330.330.330.150.160.180.200.040.46
Net Debt / EBITDA Ratio
1.787.354.633.844.194.113.463.243.995.222.867.093.783.645.152.465.092.870.685.59
Net Debt / FCF Ratio
2.2812.0214.423.584.057.104.943.044.458.635.612.445.126.232.372.103.249.000.815.72
Asset Turnover
0.120.120.130.140.150.140.130.120.120.120.110.100.100.090.090.090.110.100.100.11
Inventory Turnover
2.220.570.600.570.550.560.570.560.450.450.460.500.440.400.440.420.540.550.580.56
Quick Ratio
0.530.530.760.590.510.500.730.790.610.610.830.410.650.700.950.991.040.921.210.56
Current Ratio
0.850.851.120.880.820.791.041.110.930.901.160.941.001.051.291.311.381.251.510.88
Return on Equity (ROE)
8.16%8.16%5.30%8.91%9.59%9.23%6.21%7.80%6.92%5.85%4.97%3.05%3.95%3.78%2.07%2.26%2.89%3.95%26.20%4.95%
Return on Assets (ROA)
3.19%3.19%2.53%4.00%4.28%3.93%3.00%3.16%3.25%2.81%2.64%1.49%2.04%1.88%1.18%1.28%1.50%1.92%1.90%2.20%
Return on Invested Capital (ROIC)
4.66%4.66%3.93%6.26%6.64%6.13%4.90%5.50%5.66%4.99%5.23%2.87%3.45%3.25%2.12%2.12%2.49%3.28%3.21%3.29%
Return on Capital Employed (ROCE)
5.45%5.45%4.60%5.97%6.82%6.99%4.80%5.19%5.39%4.60%3.18%2.28%3.22%2.96%1.84%2.01%2.35%3.05%2.61%3.42%
Earnings Yield
4.82%4.57%5.19%5.70%5.67%5.73%6.03%7.46%7.38%7.63%7.03%3.86%3.76%3.73%3.69%13.51%12.78%12.92%12.84%5.60%
FCF Yield
6.25%6.02%6.69%7.96%8.25%8.06%8.46%6.42%6.45%6.41%6.49%7.57%7.28%7.95%7.32%8.28%7.38%7.18%7.57%7.94%
Dividend Yield
2.04%2.13%0.00%0.00%1.05%2.43%0.00%0.00%1.12%2.63%0.00%0.00%0.00%3.95%0.00%0.00%0.00%4.06%0.00%0.00%
Payout Ratio
44.14%196.36%0.00%0.00%61.49%147.89%0.00%0.00%74.46%193.71%0.00%0.00%0.00%316.40%0.00%0.00%0.00%337.80%0.00%0.00%
Buyback Yield / Dilution
3.79%3.18%3.74%4.29%4.20%3.75%2.95%2.31%2.34%3.02%3.95%4.82%5.25%5.23%4.57%3.28%2.08%1.24%1.27%2.09%
Total Shareholder Return
5.83%5.31%3.74%4.29%5.26%6.18%2.95%2.31%3.46%5.65%3.95%4.82%5.25%9.18%4.57%3.28%2.08%5.30%1.27%2.09%
SEC Filings: 10-K · 10-Q